Projects

DEUTSCHES KREBSFORSCHUNGSZENTRUM - Germany 

Project overview (since 2010-01-01):

<< previous next >>
Start dateProjectacronymrolefundingpartners
2018-08-01Image-based analysis for drug discovery and repurposing REMATCHcoordinator149.5001
2018-07-01Mechanism and vulnerability of BAP1 loss in tumor metastasis VulneraBAP1coordinator171.4611
2018-06-01Come and Play Science at European Researchers` Night QriUSparticipant307.57010
2018-06-01Redirecting glial progenitor fate to rebuild the injured Brain REBUILDCNScoordinator2.000.0001
2018-06-01Exploring cell interactions in the tumor microenvironment with dual ribosome profiling DualRPcoordinator1.499.3751
2018-02-01Development of strategies to eliminate cancer cells from the bone marrow ELIMINATEcoordinator1.490.8252
2018-01-01Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification MESI-STRATparticipant5.949.96417
2018-01-01MultIscale precision therapies for NeuroDEvelopmental Disorders MINDEDparticipant3.398.40016
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-10-01Detecting, understanding and exploiting intracellular redox signaling relays Redox Relayscoordinator2.006.2501
2017-09-01Centre of Excellence in Digital Health and Personalised Medicine Clinnovaparticipant399.8005
2017-07-01Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system BARCODED-CELLTRACINGparticipant2.500.0001
2017-03-01Regulation of Cellular Growth and Metabolism by C18:0 C18Signalingparticipant2.000.0001
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4coordinator7.370.00021
2016-11-07Deciphering the machinery involved in stability of the transcription factor HOXA9. HOXA9 degradomecoordinator239.8611
2016-06-01Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers EVI1inCancercoordinator1.499.0941
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2016-01-01Towards outstanding research and training in tumour biology at IMM ReTuBiparticipant999.9753
2016-01-01Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. HEP-CARparticipant5.698.31010
2016-01-01RNA EDITING IN HEALTH AND DISEASE RNAEDITparticipant2.270.0003
2015-10-01implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC ADOPT BBMRI-ERICparticipant4.949.44923
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80039
2015-09-01Statistical multi-Omics UNDerstanding of Patient Samples SOUNDparticipant2.953.06313
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTparticipant5.983.35613
2015-07-01Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy COMBIOSCOPYparticipant1.499.6993
2015-07-01Regulating the immune regulators: targeting adaptive immune control REGiREGparticipant1.955.0001
2015-06-01Dissection of tumor heterogeneity in vivo CancerHeterocoordinator2.000.0001
2015-01-01Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells IMMUNOSHAPEparticipant3.811.58115
2015-01-01Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome EpiPredictparticipant2.797.6978
2015-01-01The RANK-Axis in Breast Cancer: A comprehensive prospective evaluation of promising novel biomarkers RANKL_OPGcoordinator168.7941
2014-09-01Identifying and characterising transmembrane transporters of tryptophan and kynurenine in normal and cancerous brain tissue KP TRANSPORTcoordinator161.9691
2014-04-01Mechanisms of Mismatch repair inactivation and identification of genes suppressing mutations IMMRcoordinator100.0001
2013-11-01Immunostimulatory Agonist antibodies for Cancer Therapy IACTcoordinator5.995.74710
2013-10-01Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors REQUITEparticipant5.997.40815
2013-09-01T-cell based immunotherapy in pancreatic cancer - basic concepts and pre-clinical development TIPC_TIL_IPcoordinator100.0001
2013-06-01Analysis of Tenascin C function in breast cancer metastasis to bone BONEMETTNCcoordinator100.0001
2013-05-01Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer SUPERSISTparticipant5.999.9975
2013-05-01Deciphering the regulatory T cell repertoire: towards biomarkers and biotherapies for autoimmune diseases TRIPODparticipant2.500.0002
2013-05-01Quantitative T cell Immunology QUANTIparticipant4.012.57012
2013-02-01PIVOTAL ASSESSMENT OF THE EFFECTS OF BIOACTIVES ON HEALTH AND WELLBEING. FROM HUMAN GENOMA TO FOOD INDUSTRY - PATHWAY PATHWAY-27participant5.999.23125
2013-01-01Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action EUROFANCOLENparticipant5.380.17011
2013-01-01Early warning signals of ageing in human stem cells and age-related disorders SYSTEMAGEparticipant5.989.9259
2012-12-01Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) NET4CGDparticipant5.999.60711
2012-12-01Systems medicine of chronic inflammatory bowel disease SYSMEDIBDparticipant11.999.99812
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2participant5.900.0006
2012-08-01Infrastructure for Systems Biology - Europe ISBEparticipant4.745.71823
2012-08-01Global Mapping of Synthetic Genetic Interactions in Drosophila SYNGENEparticipant2.500.0001
2012-06-01Generating self-antigen diversity in the thymus: from gene expression patterns in single cells to the system level, an integrative approach Self-toleranceparticipant2.014.5601
2012-05-01Unlocking the potential of ultra-high-field MRI through manipulation of radiofrequency excitation fields in human tissue MRexciteparticipant2.099.9962
2012-03-07Regulation of Argonaute-2 and miRNA-dependent mRNA decay in response to oxidative stress and DNA damage mirnaAGOddrcoordinator167.3901
<< previous next >>